Showing 2 posts of 2 posts found.
As part of an effort to promote low cost medicines, the Indian government has announced plans to colour code generic …
The cost threshold NICE uses when approving drugs is too high and is doing more harm than good, new research …
Qureight paper argues for fibrosis extent as imaging biomarker in lung disease trials
START and Rome cancer institute partner to expand early-phase trial access in Italy
AbbVie expands Oxford R&D facility with new £120m UK research commitment
MedPharm appoints Jason Mieding as chief operating officer
UKRI backs five hubs developing AI tools for earlier disease detection